Studies focused on understanding the contribution of these mutations to glaucoma have revealed that some of these mutations, E50K and M98K specifically, result in modified interactions with TBK1 that influence the pathogenic activity of OPTN. The gene discussed is TBK1; the disease is glaucoma.